KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Divestments (2023 - 2025)

Historic Divestments for Royalty Pharma (RPRX) over the last 3 years, with Q3 2025 value amounting to $905000.0.

  • Royalty Pharma's Divestments fell 9212.29% to $905000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $103.4 million, marking a year-over-year increase of 31270.46%. This contributed to the annual value of $23.6 million for FY2024, which is 4612.6% down from last year.
  • According to the latest figures from Q3 2025, Royalty Pharma's Divestments is $905000.0, which was down 9212.29% from $63.0 million recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's Divestments ranged from a high of $63.0 million in Q2 2025 and a low of $905000.0 during Q3 2025
  • Moreover, its 3-year median value for Divestments was $4.8 million (2023), whereas its average is $16.8 million.
  • Examining YoY changes over the last 5 years, Royalty Pharma's Divestments showed a top increase of 149746.39% in 2025 and a maximum decrease of 9212.29% in 2025.
  • Over the past 3 years, Royalty Pharma's Divestments (Quarter) stood at $4.7 million in 2023, then crashed by 30.34% to $3.2 million in 2024, then tumbled by 72.1% to $905000.0 in 2025.
  • Its Divestments was $905000.0 in Q3 2025, compared to $63.0 million in Q2 2025 and $36.3 million in Q1 2025.